These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3052568

  • 1. Upper and lower time limits in the decision to recommend marrow transplantation for patients with chronic myelogenous leukaemia.
    Simon W, Segel GB, Lichtman MA.
    Br J Haematol; 1988 Sep; 70(1):31-6. PubMed ID: 3052568
    [Abstract] [Full Text] [Related]

  • 2. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
    Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH.
    Ann Intern Med; 1997 Dec 15; 127(12):1080-8. PubMed ID: 9412310
    [Abstract] [Full Text] [Related]

  • 3. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A.
    Bone Marrow Transplant; 1997 Oct 15; 20(7):553-60. PubMed ID: 9337056
    [Abstract] [Full Text] [Related]

  • 4. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, Frassoni F, Gahrton G, Kolb HJ, Niederwieser D, Ruutu T, Vernant JP, de Witte T, Apperley J.
    Lancet; 1998 Oct 03; 352(9134):1087-92. PubMed ID: 9798583
    [Abstract] [Full Text] [Related]

  • 5. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W, Segel GB, Lichtman MA.
    Blood Cells Mol Dis; 2006 Oct 03; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [Abstract] [Full Text] [Related]

  • 6. Variables influencing the timing of marrow transplantation in patients with chronic myelogenous leukemia.
    Segel GB, Simon W, Lichtman MA.
    Blood; 1986 Nov 03; 68(5):1055-64. PubMed ID: 3533178
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H, Davies S, McGlave P.
    Clin Transpl; 1994 Nov 03; ():283-93. PubMed ID: 7547549
    [Abstract] [Full Text] [Related]

  • 8. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ.
    Am J Med; 2001 Apr 01; 110(5):339-46. PubMed ID: 11286947
    [Abstract] [Full Text] [Related]

  • 9. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.
    van Rhee F, Lin F, Cross NC, Reid CD, Lakhani AK, Szydlo RM, Goldman JM.
    Bone Marrow Transplant; 1994 Oct 01; 14(4):609-12. PubMed ID: 7858536
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.
    N Engl J Med; 1999 Jul 01; 341(1):14-21. PubMed ID: 10387937
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
    Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A.
    Bone Marrow Transplant; 1993 Nov 01; 12(5):509-16. PubMed ID: 8298562
    [Abstract] [Full Text] [Related]

  • 12. Treatment of CML with unrelated donor marrow transplant.
    McGlave P.
    Leuk Lymphoma; 1993 Nov 01; 11 Suppl 1():209-11. PubMed ID: 8251898
    [Abstract] [Full Text] [Related]

  • 13. Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
    Gardiner N, Lawler M, O'Riordan J, De'Arce M, McCann SR.
    Leukemia; 1997 Apr 01; 11 Suppl 3():512-5. PubMed ID: 9209441
    [Abstract] [Full Text] [Related]

  • 14. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 01; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 15. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O, Hermans J, Labopin M, Apperley J, Gorin NC, Gratwohl A.
    Leuk Lymphoma; 1996 Dec 01; 24(1-2):71-9. PubMed ID: 9049963
    [Abstract] [Full Text] [Related]

  • 16. [A simple model of the optimal time for allogenic bone marrow transplantation in chronic granulocytic leukemia].
    Popović S, Pejin D, Uzurov V.
    Med Pregl; 1997 Dec 01; 50(3-4):100-2. PubMed ID: 9229678
    [Abstract] [Full Text] [Related]

  • 17. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
    Speiser DE, Hermans J, van Biezen A, Starobinski M, Jeannet M, Jacobsen N, Niederwieser D, Gratwohl A, Apperley JF.
    Bone Marrow Transplant; 1997 Jun 01; 19(12):1197-203. PubMed ID: 9208113
    [Abstract] [Full Text] [Related]

  • 18. Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation.
    Yong AS, Goldman JM.
    Bone Marrow Transplant; 1999 Apr 01; 23(8):827-8. PubMed ID: 10231146
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J, Alvarez MA, Torres A.
    Haematologica; 2000 Oct 01; 85(10):1072-82. PubMed ID: 11025600
    [Abstract] [Full Text] [Related]

  • 20. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR.
    Bone Marrow Transplant; 1996 Oct 01; 18(4):767-76. PubMed ID: 8899193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.